close
MENU
Hot Topic DEALMAKERS
Hot Topic DEALMAKERS
1 mins to read

US fund takes a liking to Ebos Group

Duncan Bridgeman
Tue, 15 Jul 2014

US investment giant Fidelity has lifted its stake in NZX-listed medical and pharmaceutical products distributor Ebos Group [NZX: EBO] above 9%.

Boston-based Fidelity purchased 1.5 million Ebos shares between May 22 and July 10, increasing its holding from 8.06% to 9.06% according to a

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Duncan Bridgeman
Tue, 15 Jul 2014
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
US fund takes a liking to Ebos Group
39594
true